Home » Abbott to Split Into Drug, Medical Device Manufacturers

Abbott to Split Into Drug, Medical Device Manufacturers

October 20, 2011

ABBOTT PARK, IL-Abbott Laboratories will split into two companies: One will focus on prescription drugs, the other will focus on medical device manufacturing. MORE

I want to hear from you. Tell me how we can improve.

BNP Media Owner & Co-CEO, Tagg Henderson

Mazda Toyota Manufacturing Invests Additional $830 Million into Alabama Plant

Honeywell Aerospace to Move Research and Development Operations

Autonomous vehicle opportunities and challenges

Automated Assembly Systems: Trimming the Timeline

LG Manufactures 1 Millionth Washing Machine in TN

Events

September 17, 2020

Automated Screwdriving with Collaborative Robots

As more companies automate their screwdriving processes with collaborative robots, there are many factors to consider to ensure employee safety, consistent required torque high degree of repeatability and zero defect products. Join Universal Robots and screwdriving experts Atlas Copco for this joint webinar featuring the latest developments in automated screwdriving.

October 1, 2020

The Lean Turnaround: How Business Leaders Use Lean Principles to Create Value and Transform Their Company

Few business leaders in the world have applied lean strategy as successfully as Art Byrne—and none has the ability to explain how to do it with such succinctness and clarity. Famous for turning around the wire management company Wiremold, where he rethought every aspect of operations from the customer’s standpoint, Byrne has successfully implemented lean strategies at more than 30 companies in 14 different countries.

View All Submit An Event

Poll

Supply Chain

The coronavirus epidemic has begun to disrupt the global manufacturing supply chain for a number of OEMs, including Airbus, Hyundai and Tesla. How resilient is your supply chain network?

Moderately resilient: We have good visibility to the supply network. It’s hard to justify investments to modify our supply chain footprint. We focus more on managing disruptions once they occur.

Highly resilient: We have good visibility to the supply network. We view flexibility and resilience as necessary investments. We can shift sourcing, manufacturing or distribution within our network fairly rapidly.

Not resilient: We are dependent on our existing sourcing, manufacturing and distribution footprint. We must find other ways to compensate for changing conditions. We have yet to invest in analytics to support network decision making.

View Results Poll Archive

Products

Manufacturing Cost Policy Deployment (MCPD) Profitability Scenarios: Systematic and Systemic Improvement of Manufacturing Costs

See More Products

Assembly Magazine

2020 September

The 2020 September Assembly features our cover story: Automated Assembly Systems: Trimming the Timeline, plus much more. Check it out today!

View More Create Account

Design, CMS, Hosting & Web Development :: ePublishing

Abbott to Split Into Drug, Medical Device Manufacturers

Related Articles